SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    H Ehrhardt, I Höfig, F Wachter, P Obexer, S Fulda, N Terziyska, I Jeremias, NOXA as critical mediator for drug combinations in polychemotherapy, Cell Death and Disease, 2012, 3, 6, e327

    CrossRef

  2. 2
    H. Ehrhardt, D. Schrembs, C. Moritz, F. Wachter, S. Haldar, U. Graubner, M. Nathrath, I. Jeremias, Optimized anti-tumor effects of anthracyclines plus Vinca alkaloids using a novel, mechanism-based application schedule, Blood, 2011, 118, 23, 6123

    CrossRef

  3. 3
    Zoe Dorothea Pana, Emmanuel Roilides, Risk of azole-enhanced vincristine neurotoxicity in pediatric patients with hematological malignancies: Old problem – New Dilemma, Pediatric Blood & Cancer, 2011, 57, 1
  4. 4
    E Kelo, T Noronkoski, I Mononen, Depletion of L-asparagine supply and apoptosis of leukemia cells induced by human glycosylasparaginase, Leukemia, 2009, 23, 6, 1167

    CrossRef

  5. 5
    H-x Sun, H-w He, S-h Zhang, T-g Liu, K-h Ren, Q-y He, R-g Shao, Suppression of N-Ras by shRNA-expressing plasmid increases sensitivity of HepG2 cells to vincristine-induced growth inhibition, Cancer Gene Therapy, 2009, 16, 9, 693

    CrossRef

  6. 6
    Marie Louise Davidsen, Kim Dalhoff, Kjeld Schmiegelow, Pharmacogenetics Influence Treatment Efficacy in Childhood Acute Lymphoblastic Leukemia, Journal of Pediatric Hematology/Oncology, 2008, 30, 11, 831

    CrossRef

  7. 7
    Tracy Anne Mewhort-Buist, Patricia C. Liaw, Sanjay Patel, Helen M. Atkinson, Leslie R. Berry, Anthony K.C. Chan, Treatment of endothelium with the chemotherapy agent vincristine affects activated protein C generation to a greater degree in newborn plasma than in adult plasma, Thrombosis Research, 2008, 122, 3, 418

    CrossRef

  8. 8
    Jae Wook Lee, Kwang Hee Lee, Young Joo Kwon, Dae Hyoung Lee, Nak Gyun Chung, Dae Chul Jeong, Bin Cho, Hack Ki Kim, The effects of shortened dexamethasone administration on remission rate and potential complications during remission induction treatment for pediatric acute lymphoblastic leukemia, Korean Journal of Pediatrics, 2007, 50, 12, 1217

    CrossRef

  9. 9
    Peter J. Houghton, Christopher L. Morton, Chandra Tucker, Debbie Payne, Edward Favours, Claire Cole, Richard Gorlick, E. Anders Kolb, Wendong Zhang, Richard Lock, Hernan Carol, Mimi Tajbakhsh, C. Patrick Reynolds, John M. Maris, Joshua Courtright, Stephen T. Keir, Henry S. Friedman, Charles Stopford, Joseph Zeidner, Jianrong Wu, Tiebin Liu, Catherine A. Billups, Javed Khan, Sherry Ansher, Jian Zhang, Malcolm A. Smith, The pediatric preclinical testing program: Description of models and early testing results, Pediatric Blood & Cancer, 2007, 49, 7
  10. 10
    Adriana Magalska, Malgorzata Sliwinska, Joanna Szczepanowska, Stefano Salvioli, Claudio Franceschi, Ewa Sikora, Resistance to apoptosis of HCW-2 cells can be overcome by curcumin- or vincristine-induced mitotic catastrophe, International Journal of Cancer, 2006, 119, 8
  11. 11
    Renato Bassan, Gemma Gatta, Carlo Tondini, Roel Willemze, Adult acute lymphoblastic leukaemia, Critical Reviews in Oncology/Hematology, 2004, 50, 3, 223

    CrossRef

  12. 12
    E.J Estlin, G.J Veal, Clinical and cellular pharmacology in relation to solid tumours of childhood, Cancer Treatment Reviews, 2003, 29, 4, 253

    CrossRef

  13. 13
    Shuichi Okada, Teruaki Hongo, Sayuri Yamada, Chieko Watanabe, Yuji Fujii, Takehiko Ohzeki, Yasuo Horikoshi, Tsuyoshi Ito, Makoto Yazaki, Yoshihiro Komada, Akio Tawa, In vitro efficacy of l-asparaginase in childhood acute myeloid leukaemia, British Journal of Haematology, 2003, 123, 5
  14. 14
    Ajay Vora, Acute Lymphoblastic Leukemia, Pediatric Drugs, 2002, 4, 6, 405

    CrossRef

  15. 15
    Ajay Vora, Acute Lymphoblastic Leukemia, Pediatric Drugs, 2002, 4, 6, 405

    CrossRef

  16. 16
    Current Awareness, Hematological Oncology, 2001, 19, 2
  17. 17
    Edward J. Estlin, Richard J. Gilbertson, Robert F. Wynn, Introduction,